|
POLA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.162040E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.991100E-04 |
| Normal-vs-Stage2 |
2.555000E-01 |
| Normal-vs-Stage3 |
9.676400E-01 |
| Normal-vs-Stage4 |
2.969400E-01 |
| Stage1-vs-Stage2 |
5.483200E-01 |
| Stage1-vs-Stage3 |
1.064390E-01 |
| Stage1-vs-Stage4 |
8.186800E-01 |
| Stage2-vs-Stage3 |
4.061800E-01 |
| Stage2-vs-Stage4 |
8.566400E-01 |
| Stage3-vs-Stage4 |
4.221000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.344460E-02 |
| Normal-vs-AfricanAmerican |
4.508400E-02 |
| Normal-vs-Asian |
9.856300E-02 |
| Caucasian-vs-AfricanAmerican |
9.322000E-01 |
| Caucasian-vs-Asian |
7.963600E-01 |
| AfricanAmerican-vs-Asian |
7.984800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81650999999672E-05 |
| Normal-vs-Female |
8.543900E-02 |
| Male-vs-Female |
3.76349999997583E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.774040E-01 |
| Normal-vs-Extreme_Weight |
1.59683999999549E-05 |
| Normal-vs-Obese |
7.378400E-01 |
| Normal-vs-Extreme_Obese |
1.66256999999392E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.016010E-01 |
| Normal_Weight-vs-Obese |
3.863200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.239730E-02 |
| Extreme_Weight-vs-Obese |
4.118600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.724200E-01 |
| Obese-vs-Extreme_Obese |
7.041200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.494400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.290400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.027800E-04 |
| Normal-vs-Age(81-100Yrs) |
5.576000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.362750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.758200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.458100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.650310E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.961210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.604800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.243900E-04 |
| Normal-VS-Type2 PRCC |
7.606000E-02 |
| Normal-VS-KIRP CIMP |
4.584600E-01 |
| Normal-VS-Unclassified PRCC |
8.584600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.877200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.616830E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.197900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.354200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.727200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.974000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.442800E-03 |
| Normal-vs-N1 |
4.041600E-01 |
| Normal-vs-N2 |
2.812600E-01 |
| N0-vs-N1 |
3.683800E-02 |
| N0-vs-N2 |
1.417590E-01 |
| N1-vs-N2 |
9.586600E-01 |
|
|
